Compelling evidence has shown that inhibition of NF-κB nuclear translocation or phosphorylation alleviates IR-mediated cytokine production and brain inflammation (Colombo and Farina, 2016; Liu et al., 2019; Xie et al., 2019; Bai et al., 2020). The gene discussed is NFKB1; the disease is brain inflammatory disease.